Paragonix Technologies, a leading organ transplant company, announces that it has entered into a definitive agreement to be acquired by Getinge. This strategic acquisition will enhance Getinge’s global healthcare portfolio to also address needs in solid organ transplantation. Paragonix has led the way in developing a platform of groundbreaking organ preservation technologies, driving a shift within the clinical transplant community and redefining the standard of care in organ transplantation. Today, Paragonix is the leading US cardiothoracic organ preservation technology provider and is rapidly expanding in abdominal transplantation.
Read the full article: Paragonix Technologies Signs Definitive Agreement to Be Acquired by Getinge //
Source: https://www.businesswire.com/news/home/20240822548787/en/Paragonix-Technologies-Signs-Definitive-Agreement-to-be-Acquired-by-Getinge